These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

421 related articles for article (PubMed ID: 31288625)

  • 21. New roles for the LKB1-->AMPK pathway.
    Hardie DG
    Curr Opin Cell Biol; 2005 Apr; 17(2):167-73. PubMed ID: 15780593
    [TBL] [Abstract][Full Text] [Related]  

  • 22. AMP-activated protein kinase and human cancer: cancer metabolism revisited.
    Kuhajda FP
    Int J Obes (Lond); 2008 Sep; 32 Suppl 4(Suppl 1):S36-41. PubMed ID: 18719597
    [TBL] [Abstract][Full Text] [Related]  

  • 23. AMP-activated protein kinase: a key regulator of energy balance with many roles in human disease.
    Grahame Hardie D
    J Intern Med; 2014 Dec; 276(6):543-59. PubMed ID: 24824502
    [TBL] [Abstract][Full Text] [Related]  

  • 24. LKB1 and AMP-activated protein kinase control of mTOR signalling and growth.
    Shaw RJ
    Acta Physiol (Oxf); 2009 May; 196(1):65-80. PubMed ID: 19245654
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The AMP-activated protein kinase (AMPK) and cancer: many faces of a metabolic regulator.
    Faubert B; Vincent EE; Poffenberger MC; Jones RG
    Cancer Lett; 2015 Jan; 356(2 Pt A):165-70. PubMed ID: 24486219
    [TBL] [Abstract][Full Text] [Related]  

  • 26. β-Subunit myristoylation is the gatekeeper for initiating metabolic stress sensing by AMP-activated protein kinase (AMPK).
    Oakhill JS; Chen ZP; Scott JW; Steel R; Castelli LA; Ling N; Macaulay SL; Kemp BE
    Proc Natl Acad Sci U S A; 2010 Nov; 107(45):19237-41. PubMed ID: 20974912
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New insights into activation and function of the AMPK.
    Steinberg GR; Hardie DG
    Nat Rev Mol Cell Biol; 2023 Apr; 24(4):255-272. PubMed ID: 36316383
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeting AMPK: From Ancient Drugs to New Small-Molecule Activators.
    Guigas B; Viollet B
    Exp Suppl; 2016; 107():327-350. PubMed ID: 27812986
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Frequent loss-of-function mutations in the AMPK-α2 catalytic subunit suggest a tumour suppressor role in human skin cancers.
    Ross FA; Hawley SA; Russell FM; Goodman N; Hardie DG
    Biochem J; 2023 Dec; 480(23):1951-1968. PubMed ID: 37962491
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeting AMP-activated protein kinase as a novel therapeutic approach for the treatment of metabolic disorders.
    Viollet B; Mounier R; Leclerc J; Yazigi A; Foretz M; Andreelli F
    Diabetes Metab; 2007 Dec; 33(6):395-402. PubMed ID: 17997341
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Keeping the home fires burning: AMP-activated protein kinase.
    Hardie DG
    J R Soc Interface; 2018 Jan; 15(138):. PubMed ID: 29343628
    [TBL] [Abstract][Full Text] [Related]  

  • 32. AMPK: An Energy-Sensing Pathway with Multiple Inputs and Outputs.
    Hardie DG; Schaffer BE; Brunet A
    Trends Cell Biol; 2016 Mar; 26(3):190-201. PubMed ID: 26616193
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Regulation of energy metabolism by AMPK: a novel therapeutic approach for the treatment of metabolic and cardiovascular diseases].
    Foretz M; Taleux N; Guigas B; Horman S; Beauloye C; Andreelli F; Bertrand L; Viollet B
    Med Sci (Paris); 2006 Apr; 22(4):381-8. PubMed ID: 16597407
    [TBL] [Abstract][Full Text] [Related]  

  • 34. LKB1 and AMPK maintain epithelial cell polarity under energetic stress.
    Mirouse V; Swick LL; Kazgan N; St Johnston D; Brenman JE
    J Cell Biol; 2007 May; 177(3):387-92. PubMed ID: 17470638
    [TBL] [Abstract][Full Text] [Related]  

  • 35. AMPK Causes Cell Cycle Arrest in LKB1-Deficient Cells via Activation of CAMKK2.
    Fogarty S; Ross FA; Vara Ciruelos D; Gray A; Gowans GJ; Hardie DG
    Mol Cancer Res; 2016 Aug; 14(8):683-95. PubMed ID: 27141100
    [TBL] [Abstract][Full Text] [Related]  

  • 36. AMP-activated protein kinase pathway: a potential therapeutic target in cardiometabolic disease.
    Wong AK; Howie J; Petrie JR; Lang CC
    Clin Sci (Lond); 2009 Apr; 116(8):607-20. PubMed ID: 19275766
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Deletion of Lkb1 in pro-opiomelanocortin neurons impairs peripheral glucose homeostasis in mice.
    Claret M; Smith MA; Knauf C; Al-Qassab H; Woods A; Heslegrave A; Piipari K; Emmanuel JJ; Colom A; Valet P; Cani PD; Begum G; White A; Mucket P; Peters M; Mizuno K; Batterham RL; Giese KP; Ashworth A; Burcelin R; Ashford ML; Carling D; Withers DJ
    Diabetes; 2011 Mar; 60(3):735-45. PubMed ID: 21266325
    [TBL] [Abstract][Full Text] [Related]  

  • 38. AMPK signalling in health and disease.
    Carling D
    Curr Opin Cell Biol; 2017 Apr; 45():31-37. PubMed ID: 28232179
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metformin and cancer.
    Vallianou NG; Evangelopoulos A; Kazazis C
    Rev Diabet Stud; 2013; 10(4):228-35. PubMed ID: 24841876
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of AMPK signalling by doxorubicin: at the crossroads of the cardiac responses to energetic, oxidative, and genotoxic stress.
    Gratia S; Kay L; Potenza L; Seffouh A; Novel-Chaté V; Schnebelen C; Sestili P; Schlattner U; Tokarska-Schlattner M
    Cardiovasc Res; 2012 Aug; 95(3):290-9. PubMed ID: 22461523
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.